Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

06. Januar 2011 07:00 ET | Quelle: Athersys, Inc.

Athersys Announces Completion of Patient Enrollment for Single Dose Arm of Phase I Study of MultiStem(R) for Hematopoietic Stem Cell Transplant Support

CLEVELAND, Jan. 6, 2011 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has completed patient enrollment of the single dose arm of a clinical study involving administration of...
29. November 2010 07:00 ET | Quelle: Athersys, Inc.

Athersys to Present at the 22nd Annual Piper Jaffray Health Care Conference

CLEVELAND, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Athersys is scheduled to present at the 22 nd Annual Piper Jaffray Health Care Conference to be held...
10. November 2010 16:15 ET | Quelle: Athersys, Inc.

Athersys to Present at Lazard Capital Markets Healthcare Conference

CLEVELAND, Nov. 10, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that the Company is scheduled to present at the Lazard Capital Markets Seventh Annual Healthcare Conference,...
08. November 2010 16:12 ET | Quelle: Athersys, Inc.

Athersys Reports Third Quarter 2010 Results

CLEVELAND, Nov. 8, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended September 30, 2010. Third Quarter and Recent Highlights...
08. November 2010 07:30 ET | Quelle: Athersys, Inc.

Athersys Announces FDA Authorization of Phase II Clinical Trial for Inflammatory Bowel Disease With Pfizer Regenerative Medicine

CLEVELAND, Nov. 8, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that the U.S. Food and Drug Administration (FDA) has authorized commencement of a Phase II clinical trial...
04. November 2010 07:00 ET | Quelle: Athersys, Inc.

Athersys Secures Multiple Grants to Advance Key Therapeutic Programs in Regenerative Medicine and Obesity

CLEVELAND, Ohio, Nov. 4, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has secured three Therapeutic Discovery Project grants as part of the Patient Protection and...
21. Oktober 2010 14:00 ET | Quelle: Athersys, Inc.

Athersys to Present at BioCentury NewsMakers in the Biotech Industry Conference

CLEVELAND, Oct. 21, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Gil Van Bokkelen Ph.D., Chairman and Chief Executive Officer, will present at the BioCentury NewsMakers...
20. Oktober 2010 08:30 ET | Quelle: Athersys, Inc.

Ismail Kola Elected to Athersys Board of Directors

CLEVELAND, Oct. 20, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that the Company's Board of Directors unanimously voted to elect Ismail Kola, Ph.D., as a director of the...
14. Oktober 2010 17:00 ET | Quelle: Athersys, Inc.

Athersys to Host Third Quarter Financial Results Call

CLEVELAND, Oct. 14, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its third quarter financial results at approximately 4:00 PM Eastern Time (ET) on...
23. September 2010 07:00 ET | Quelle: Athersys, Inc.

Athersys' Phase I Study of MultiStem in Heart Attack Patients Presented at Transcatheter Cardiovascular Therapeutics Conference 2010

CLEVELAND, Sept. 23, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced at its presentation at the Transvascular Cardiovascular Therapeutics (TCT) Conference held in Washington, D.C.,...

Vorherige Seite